Concepedia
Statistics
Publications
14
Citations
432
H-Index
13
Active since
1994
Affiliations
Roche Pharma AG (Germany)(Current)
University of Konstanz
Roche (Switzerland)
La Roche College
Charité - Universitätsmedizin Berlin
Frank Bergmann is an author at Roche Pharma AG (Germany) specializing in nucleic acid synthesis, pharmacy, and bioorthogonal chemistry.
Publications per year
1994–2021
A Convergent Strategy for the Modification of Peptide Nucleic Acids: Novel Mismatch-Specific PNA-Hybridization Probes
Oliver Seitz, Frank Bergmann, Dieter Heindl · Angewandte Chemie International Edition · 1999 · 77 citations
Pharmacy, Biochemistry, Biotechnology +17
Solid phase synthesis of directly linked PNA-DNA-hybrids
Frank Bergmann, Willi Bannwarth, Steve Tam · Tetrahedron Letters · 1995 · 69 citations
Pharmacy, Biotechnology, Materials Science +10
Discovery of a microbial transglutaminase enabling highly site-specific labeling of proteins
Wojtek Steffen, Fu Chong Ko, Jigar Patel et al. · Journal of Biological Chemistry · 2017 · 66 citations · Full text
Life Sciences, Biochemistry, Biotechnology +17
Solid phase synthesis of directly linked peptide-oligodeoxynucleotide hybrids using standard synthesis protocols
Frank Bergmann, Willi Bannwarth · Tetrahedron Letters · 1995 · 39 citations
Pharmacy, Biotechnology, Molecular Biology +13
Nucleotides. Part XLI. The 2‐dansylethoxycarbonyl ( 2‐{[5‐(dimethylamino)naphthalen‐1‐yl]sulfonyl}ethoxycarbonyl; dnseoc) group for protection of the 5′‐hydroxy function in oligodeoxyribonucleotide synthesis
Frank Bergmann, Wolfgang Pfleiderer · Helvetica Chimica Acta · 1994 · 32 citations
Pharmacy, Biotechnology, Molecular Biology +16
1–5 of 14